Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A5PK19

Entry ID Method Resolution Chain Position Source
AF-A5PK19-F1 Predicted AlphaFoldDB

115 variants for A5PK19

Variant ID(s) Position Change Description Diseaes Association Provenance
rs443080884 16 Y>S No EVA
rs456804229 23 Q>H No EVA
rs433268987 29 F>L No EVA
rs476930460 31 W>R No EVA
rs438815976 40 G>W No EVA
rs479112426 48 P>T No EVA
rs461117185 49 R>S No EVA
rs481298748 50 E>Q No EVA
rs444035091 52 V>G No EVA
rs475732698 52 V>M No EVA
rs440103641 53 L>R No EVA
rs477855399 53 L>V No EVA
rs459866416 54 V>G No EVA
rs480028595 57 C>G No EVA
rs448613672 57 C>W No EVA
rs450750502 60 S>* No EVA
rs482369639 60 S>P No EVA
rs464403922 61 E>* No EVA
rs433240174 61 E>A No EVA
rs453404701 61 E>D No EVA
rs467068610 63 S>R No EVA
rs3423649349 63 S>T No EVA
rs521816765 90 R>C No EVA
rs435359666 118 V>A No EVA
rs526558472 131 E>K No EVA
rs876442452 139 V>G No EVA
rs876156092 146 V>G No EVA
rs876450144 149 V>G No EVA
rs455568873 150 L>M No EVA
rs475695972 152 V>G No EVA
rs444353887 156 Y>* No EVA
rs451282158 168 K>T No EVA
rs797353883 176 R>Q No EVA
rs440021018 177 E>A No EVA
rs440021018 177 E>G No EVA
rs460233299 179 W>G No EVA
rs473947200 187 A>D No EVA
rs462184427 191 D>G No EVA
rs442202350 191 D>N No EVA
rs451117159 194 L>W No EVA
rs457954539 195 E>D No EVA
rs446840273 205 F>V No EVA
rs467080418 209 M>I No EVA
rs435730077 214 P>R No EVA
rs109431475 215 V>F No EVA
rs469185818 216 T>P No EVA
rs451596628 223 F>L No EVA
rs471707054 230 Q>R No EVA
rs453688239 234 V>G No EVA
rs135778370 248 E>G No EVA
rs442485662 253 A>G No EVA
rs475834558 260 Y>S No EVA
rs444630517 261 R>L No EVA
rs478587192 264 G>R No EVA
rs446831652 267 S>R No EVA
rs460505559 268 V>E No EVA
rs460505559 268 V>G No EVA
rs480715446 269 S>A No EVA
rs469503895 271 D>Y No EVA
rs437781696 276 D>A No EVA
rs445092926 279 E>A No EVA
rs465265150 279 E>D No EVA
rs445092926 279 E>G No EVA
rs433873154 283 T>P No EVA
rs453645015 284 L>H No EVA
rs453645015 284 L>R No EVA
rs456056044 288 D>G No EVA
rs476151347 294 P>T No EVA
rs1114787175 296 R>W No EVA
rs451856326 297 D>E No EVA
rs472079522 300 F>Y No EVA
rs453043346 305 I>M No EVA
rs474449073 310 E>D No EVA
rs456493700 312 E>D No EVA
rs436696978 312 E>G No EVA
rs476623422 313 W>R No EVA
rs473098327 315 F>V No EVA
rs458967424 332 R>G No EVA
rs440989885 346 G>D No EVA
rs481081409 347 M>L No EVA
rs449910830 347 M>R No EVA
rs463159436 348 D>N No EVA
rs463159436 348 D>Y No EVA
rs477026006 350 I>F No EVA
rs445662749 353 E>A No EVA
rs465819692 359 M>V No EVA
rs461944894 363 P>L No EVA
rs434479486 366 M>I No EVA
rs455304829 368 A>S No EVA
rs447746998 369 Q>H No EVA
rs479919575 377 V>G No EVA
rs209639597 386 V>I No EVA
rs876180505 410 Y>F No EVA
rs876066822 453 T>P No EVA
rs444657708 464 S>A No EVA
rs451897216 476 K>Q No EVA
rs472171636 481 G>S No EVA
rs461074531 527 D>G No EVA
rs720525515 533 V>E No EVA
rs443153498 545 R>L No EVA
rs211520609 555 D>Y No EVA
rs482342390 571 V>G No EVA
rs450873652 575 D>G No EVA
rs464699390 591 A>P No EVA
rs477988464 595 Q>H No EVA
rs467255679 611 F>L No EVA
rs465708392 650 L>R No EVA
rs433913602 652 C>S No EVA
rs432528282 652 C>S No EVA
rs454131979 655 H>R No EVA
rs474272641 662 T>P No EVA
rs442943142 667 E>D No EVA
rs456598504 675 T>P No EVA
rs476413114 678 K>T No EVA
rs458628651 697 K>Q No EVA

No associated diseases with A5PK19

No regional properties for A5PK19

Type Name Position InterPro Accession
No domain, repeats, and functional sites for A5PK19

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Mitochondrion
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

1 GO annotations of molecular function

Name Definition
methyltransferase activity Catalysis of the transfer of a methyl group to an acceptor molecule.

3 GO annotations of biological process

Name Definition
methylation The process in which a methyl group is covalently attached to a molecule.
negative regulation of cell cycle G1/S phase transition Any signalling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9VIK9 CG2614 eEF1A lysine and N-terminal methyltransferase homolog Drosophila melanogaster (Fruit fly) PR
Q8N6R0 METTL13 eEF1A lysine and N-terminal methyltransferase Homo sapiens (Human) PR
10 20 30 40 50 60
MNLLPKSSKE FGSVDYWEKF FQQRGKKAFE WYGTYLELCG VLHKYIKPRE KVLVVGCGNS
70 80 90 100 110 120
ELSEQLYDVG YQDIVNIDIS EVVIKQMKER NASRRPRMSF LKMDMTQMEF PDASFQVVLD
130 140 150 160 170 180
KGTLDAVLTD EEEKTLQQVD RMLAEVGRVL QVGGRYLCIS LAQAHVLKKA VGHFSREGWM
190 200 210 220 230 240
VRVHQVASSQ DQLLEAEPRF SLPVFAFIMT KFRPVTGSAL QIFELCAQEQ GKPVRLESAE
250 260 270 280 290 300
QLAEAVRERQ QYAWLCSQLY RKAGLGSVSL DLCNGDTGEP RYTLHVVDSP TVKPSRDNHF
310 320 330 340 350 360
AIFIIPQGRE TEWLFGMEEG RKQLAASAGF RRLITVALHR GQQYEGMDSI QAELSARVME
370 380 390 400 410 420
LAPAGMPAQL QVPFLSVGGD IGVRIVQHQA CSPLSGDYVI EDVQGDDKRY FRRLIFLSNR
430 440 450 460 470 480
NVVQSEARLL QDVSHRAQKK RKKDRKKHRP ADTPEDLPAA QGQSIDKSYL CCEHHKAMIA
490 500 510 520 530 540
GLALLKNPEL LLETPLALLV VGLGGGSLPL FIHDHFPKSC IHAVEIDPSM LEVATQWFGF
550 560 570 580 590 600
SQSDRMKVHI ADGLDFITRL AEEEARPHYD VIMFDVDSKD PTLGMSCPPP AFVAQLFLQK
610 620 630 640 650 660
VKSILTPEGV FILNLVCRDL GLKDSVLAGL KAVFPLLYVR RIEGEVNEIL FCQLHSECKL
670 680 690
ATPELLEMAR ALEQTLRKPG KGWDDTYVLS DMLNTVKIV